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Sir,  
In a previous report, we described the first case of a mother-to-child transmission of KPC 
carbapenemase-producing Klebsiella pneumoniae (KPC-KP) at birth, in an extremely low birth 
weight infant who developed sepsis caused by KPC-KP during the first week. The case was 
followed by a small outbreak of KPC-KP in the neonatal intensive care unit, which was controlled 
by the implementation of strict infection control measures [1]. Here we describe a new case of 
mother-to-child transmission of KPC-KP (involving two twins), that highlights the potential 
relevance of low urinary microbial loads in pregnancy for screening purposes. 
 
The mother was a 32-weeks pregnant Italian citizen, admitted to the A. Manzoni Hospital of Lecco 
(Northern Italy) for preterm premature rupture of membranes. The clinical conditions were good, 
with no fever or signs of sepsis. No risk factors for MDR organisms were known. Ampicillin (2 g 
every 6 hours) and clarithromycin (500 mg every 12 hours) were given for 6 days, in accordance 
with the guidelines for the management of women with preterm premature rupture of 
membranes  [2]. 
 
Three days after admission a surveillance urine culture yielded a K. pneumoniae at very low 
microbial load (≈1,000 CFU/ml). Despite the microbial load was below the significance level for 
uncomplicated urinary tract infection in pregnant women  [3], the isolate was further investigated 
as part of an ongoing study protocol on carbapenem-resistant urinary tract isolates of 
Enterobacteriaceae. Antimicrobial susceptibility testing, carried out by broth microdilution (CLSI) 
and interpreted according to the 7.1 EUCAST clinical breakpoints (www.eucast.org), revealed that 
the isolate was resistant to extended-spectrum cephalosporins, carbapenems, and 
fluoroquinolones, and susceptible to aminoglycosides (amikacin and gentamicin), colistin, 
tigecycline, trimethoprim/sulfamethoxazole, and ceftazidime-avibactam (Table I). Rapid molecular 
analysis by the GeneXpert system (Xpert Carba-R, Cepheid, Sunnivale, CA) yielded a positive result 
for KPC carbapenemase gene, that was immediately communicated to clinicians. KPC-KP was 
subsequently isolated also from a rectal swab of the mother, and from the amniotic fluid collected 
at delivery (11 days after admission), while the routine culture from the placenta specimen 
(collected at birth) was negative. 
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At birth, the infants had a low weight (1756 g and 1780 g, respectively) but were in overall good 
clinical conditions. Microbiological screening, performed by throat and auricular swabs, taken 
after delivery, yielded negative results for KPC-KP. However, subsequent cultures of throat and 
rectal swabs from twin #1 (taken three days after delivery in both cases), and of conjunctival and 
rectal swabs from twin #2 (taken six and 13 days after delivery, respectively), resulted positive for 
KPC-KP. Since no signs of infection was present, no antimicrobial treatment was given to the 
infants, and the presence of KPC-KP was regarded as a colonization event. Both children were 
discharged after 24 days in good clinical conditions (twin #1, 2245 g; twin #2, 2330 g). 
 
Further molecular analysis of the KPC-KP isolates (LC-1296/16, LC-1315/16, LC-1354/16, and 
LC1312/16), carried out by whole genome sequencing (HiSeq Illumina platform, Illumina, San 
Diego, CA, USA) revealed that all the isolates belonged to the same sequence type (ST) 307 and 
that all carried the same pattern of acquired resistance genes (including the blaKPC-3 and blaSHV-28 
beta-lactamases) (Table I). Core genome SNP analysis, carried out using the CSI Phylogeny tool 
(https://cge.cbs.dtu.dk/services/CSIPhylogeny), demonstrated that the isolates were closely 
related to each other (SNPs differences range: 0-2) (Table II). These data confirmed that the strains 
from the mother and those from the two twins were the same. 
 
Despite the absence of signs and symptoms of infection, screening and treatment of 
asymptomatic bacteriuria in pregnancy is currently a commonly recommended practice in several 
countries. However, only microbial loads of at least 105 CFU/ml are considered significant and 
reported by the laboratory [3, 4]. 
 
To the best of our knowledge, this is the first report that demonstrates the importance of taking 
into account a low microbial load of KPC-KP from urine samples in pregnancy as a risk factor for 
the mother-to child transmission of KPC-KP at birth. In our case, prompt communication of KPC-KP 
positivity enabled the maternity unit to rapidly implement strict infection control measures and 
limit hospital transmission. In fact, the mother, and subsequently the infants, were subjected to 
isolation regimen during hospitalization, and a dedicated staff was assigned to their care. In 
particular, the two infants were located in different boxes separated from other newborns, with a 
larger spacing between cots. Other measures such as improvement of hand hygiene compliance 
and deep cleaning of environment and equipment were adopted. No additional cases of KPC-KP 
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cross-transmissions were detected in the maternity unit. Based on this experience, screening of 
urine samples for resistant pathogens, even if at low load (below the clinical significance level), 
could be important in preventing their spread in the maternity units. 
 
Conflict of interest statement 
None declared. 
 
Funding sources 
None. 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
References 
 
[1] Bonfanti P, Bellù R, Principe L, Caramma I, Condò M, Giani T, et al. Mother-to-child 
transmission of KPC carbapenemase-producing Klebsiella pneumoniae at birth. Pediatr Infect 
Dis J 2017;36:228-9. 
 
[2] Yudin MH, van Schalkwyk J, Van Eyk N, Boucher M, Castillo E, Cormier B, et al. Society of 
Obstetricians and Gynaecologists of Canada. Antibiotic therapy in preterm premature rupture 
of the membranes. J Obstet Gynaecol Can 2009;31:863–7, 868-74. 
 
[3] Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of 
America; American Society of Nephrology; American Geriatric Society. Infectious Diseases 
Society of America guidelines for the diagnosis and  treatment of asymptomatic bacteriuria in 
adults. Clin Infect Dis 2005;40:643-54. 
 
[4] Gilbert NM, O'Brien VP, Hultgren S, Macones G, Lewis WG, Lewis AL. Urinary tract infection as 
a preventable cause of pregnancy complications: opportunities, challenges, and a global call 
to action. Glob Adv Health Med 2013;2:59-69. 
 
 
 
Web References 
 
The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for 
interpretation of MICs and zone diameters. Version 7.1, 2017: http://www.eucast.org. 
 
Center for Genomic Epidemiology. CSI Phylogeny 1.4 (Call SNPs & Infer Phylogeny): 
https://cge.cbs.dtu.dk/services/CSIPhylogeny/ 
 
MA
NU
SC
RIP
T
 
AC
CE
PT
ED
A
C
C
EP
TE
D
 M
A
N
U
SC
R
IP
T
Ta
ble
 I. 
Su
sce
pti
bil
ity
 pr
ofi
le 
of 
KP
C-
pro
du
cin
g K
leb
sie
lla
 pn
eu
mo
nia
e i
so
lat
es 
 *M
IC
 v
alu
es 
ind
ica
te 
mi
nim
al 
inh
ibi
tor
y c
on
ce
ntr
ati
on
s, 
as 
ob
tai
ne
d 
by
 st
an
da
rd 
bro
th 
mi
cro
dil
uti
on
 m
eth
od
. I
nte
rpr
eta
tio
n 
ba
sed
 o
n 
cu
rre
nt 
EU
CA
ST
 
cri
ter
ia 
(ht
tp:
//w
ww
.eu
ca
st.
org
). 
Ab
bre
via
tio
ns
: A
C,
 am
ox
ici
llin
-cl
av
ula
na
te;
 A
K,
 am
ika
cin
; A
Z,
 az
tre
on
am
; C
Z, 
ce
fta
zid
im
e; 
CZ
A,
 ce
fta
zid
im
e-a
vib
ac
tam
; C
I, c
ipr
ofl
ox
ac
in;
 C
O,
 co
lis
tin
; 
CT
, c
efo
tax
im
e; 
ET
, e
rta
pe
ne
m;
 F
P, 
ce
fep
im
e; 
GN
, g
en
tam
ici
n; 
IM
, i
mi
pe
ne
m;
 M
R,
 m
ero
pe
ne
m;
 P
T,
 p
ipe
rac
illi
n-t
az
ob
ac
tam
; S
T,
 tr
im
eth
op
rim
–
su
lfa
me
tho
xa
zo
le;
 S,
 su
sce
pti
ble
; I
, in
ter
me
dia
te;
 R
, re
sis
tan
t. 
 Pat
ien
t 
Co
de
 
So
urc
e 
ST
 
Ac
qu
ire
d 
res
ist
an
ce
 
de
ter
mi
na
nts
 
 
M
IC
 va
lue
s (
S, 
I, R
)* 
of 
va
rio
us
 an
tim
icr
ob
ial
 ag
en
ts 
AC
 
AZ
 
PT
 
CZ
 
CT
 
FP
 
ET
 
IM
 
M
R 
AK
 
GN
 
CI
 
TG
 
CO
 
ST
 
CZ
A 
M
oth
er 
LC
-
12
96
/16
 
Ur
ine
 
30
7 
bla
KP
C-
3; 
bla
SH
V-
28
; 
str
AB
    
    
    
>3
2/2
 
(R
) 
64
 
(R
) 
64
 
(R
) 
>1
6 
(R
) 
>4
 
(R
) 
8 (R
) 
>4
 
(R
) 
8 (I)
 
8 (I)
 
0.5
 
(S
) 
<=
0,5
 
(S
) 
4 (R
) 
0.5
 
(S
) 
0.5
 
(S
) 
<=
0,5
/9,
5 
(S
) 
0.5
 
(S
) 
Tw
in 
#1
 
LC
-
13
15
/16
 
Re
cta
l 
sw
ab
 
30
7 
bla
KP
C-
3; 
bla
SH
V-
28
; 
str
AB
 
>3
2/2
 
(R
) 
>6
4 
(R
) 
>6
4 
(R
) 
>1
6 
(R
) 
>4
 
(R
) 
>8
 
(R
) 
>4
 
(R
) 
8 (I)
 
>8
 
(R
) 
0.5
 
(S
) 
<=
0,5
 
(S
) 
4 (R
) 
0.5
 
(S
) 
0.5
 
(S
) 
<=
0,5
/9,
5 
(S
) 
0.5
 
(S
) 
Tw
in 
#2
 
LC
-
13
54
/16
 
Re
cta
l 
sw
ab
 
30
7 
bla
KP
C-
3; 
bla
SH
V-
28
; 
str
AB
 
>3
2/2
 
(R
) 
>6
4 
(R
) 
64
 
(R
) 
>1
6 
(R
) 
>4
 
(R
) 
>8
 
(R
) 
>4
 
(R
) 
8 (I)
 
>8
 
(R
) 
0.5
 
(S
) 
<=
0,5
 
(S
) 
4 (R
) 
0.5
 
(S
) 
0.5
 
(S
) 
<=
0,5
/9,
5 
(S
) 
2 (S
) 
M
oth
er 
 
LC
-
13
12
/16
 
Am
nio
tic
 
flu
id 
30
7 
bla
KP
C-
3; 
bla
SH
V-
28
; 
str
AB
 
>3
2/2
 
(R
) 
>6
4 
(R
) 
64
 
(R
) 
>1
6 
(R
) 
>4
 
(R
) 
>8
 
(R
) 
>4
 
(R
) 
8 (I)
 
8 (R
) 
4 (S
) 
<=
0,5
 
(S
) 
4 (R
) 
0.5
 
(S
) 
0.5
 
(S
) 
<=
0,5
/9,
5 
(S
) 
2 (S
) 
MA
NU
SC
RIP
T
 
AC
CE
PT
ED
A
C
C
EP
TE
D
 M
A
N
U
SC
R
IP
T
   Ta
ble
 II
. C
ha
rac
ter
ist
ics
 of
 K
leb
sie
lla
 pn
eu
mo
nia
e i
so
lat
es 
typ
ed
 by
 w
ho
le 
ge
no
me
 se
qu
en
cin
g. 
Pa
tie
nt
 
Co
de
 
Co
re
 ge
no
me
 SN
Ps
#  
Co
nt
igs
 
(n
) 
N5
0 
(b
p)
 
L5
0 
(n
) 
To
tal
 le
ng
th
 
(b
p)
 
LC
-12
96
/16
 
LC
13
12
/16
 
LC
-13
15
/16
 
LC
-13
54
/16
 
M
oth
er 
LC
-12
96
/16
 
0 
1 
1 
1 
76
 
20
32
58
 
9 
54
23
72
2 
M
oth
er 
LC
13
12
/16
 
1 
0 
2 
0 
58
 
28
87
90
 
6 
54
30
12
0 
Tw
in 
#1
 
LC
-13
15
/16
 
1 
2 
0 
2 
69
 
20
35
49
 
7 
54
29
13
2 
Tw
in 
#2
 
LC
-13
54
/16
 
1 
0 
2 
0 
69
 
30
76
00
 
6 
54
33
43
3 
 # T
he
 co
re 
ge
no
me
 SN
Ps
 an
aly
sis
 w
as 
pe
rfo
rm
ed
 us
ing
 th
e S
T3
07
 K
. p
ne
um
on
iae
 st
rai
n K
PN
11
 (A
cc
. n
o. 
NZ
_N
CT
N0
00
00
00
0.0
) a
s r
efe
ren
ce
. 
